ClinicalTrials.Veeva

Menu

Comparison of Three Soft Bifocal Contact Lenses

Johnson & Johnson (J&J) logo

Johnson & Johnson (J&J)

Status

Completed

Conditions

Presbyopia

Treatments

Device: senofilcon A test
Device: balafilcon A
Device: senofilcon A production

Study type

Interventional

Funder types

Industry

Identifiers

NCT00808340
CR-1485FA

Details and patient eligibility

About

The primary purpose of the study is to compare the performance of three soft bifocal contact lenses in terms of the vision provided by the lenses.

Enrollment

37 patients

Sex

All

Ages

35 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The subject must between 35 and 70 years of age.
  • The subject must respond positively to at least one symptom on the "Presbyopic Symptoms Questionnaire" or be already wearing presbyopic contact lens correction ( e.g. reading spectacles over contact lenses, multifocal or monovision contact lenses etc.).
  • The subject's spherical equivalent distance refraction must be in the range of -1.00 to -6.00 in each eye.
  • Refractive cylinder must be less than or equal to -0.75 D in each eye.
  • The subject must have an add power of +0.75D to +2.50D in each eye.
  • The subject must have best corrected visual acuity of 20/20-3 or better in each eye.
  • The subject's must have at least 20/30-distance vision with the study contact lenses.
  • The subject must agree that they are comfortable with their vision prior to being dispensed the study lenses.
  • The subject must be an adapted soft contact lens wearer in both eyes.
  • The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
  • The subject must read and sign the STATEMENT OF INFORMED CONSENT and be provided a copy of the form.

Exclusion criteria

  • Ocular or systemic allergies or disease that may interfere with contact lens wear.
  • Systemic disease, autoimmune disease or use of medication, which may interfere with contact lens wear.
  • Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining or any other abnormality of the cornea, which may contraindicate contact lens wear.
  • Clinically significant (grade 3 or 4) tarsal abnormalities that might interfere with contact lens wear.
  • Any ocular infection.
  • Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
  • Pregnancy or lactation
  • Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g., HIV).
  • History of diabetes. History of binocular vision abnormality or strabismus.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

37 participants in 6 patient groups

senofilA test/senofilA prod/balafilconA
Active Comparator group
Description:
Subjects wear 3 multifocal contact lenses: senofilcon A test worn first, senofilcon A production worn second, and balafilcon A worn third.
Treatment:
Device: balafilcon A
Device: senofilcon A production
Device: senofilcon A test
senofilcon A test/balafilcon A/senofilcon A prod
Active Comparator group
Description:
Subjects wear 3 multifocal contact lenses: senofilcon A test worn first, balafilcon A worn second, and senofilcon A production worn third.
Treatment:
Device: balafilcon A
Device: senofilcon A production
Device: senofilcon A test
senofilcon A prod/senofilcon A test/balafilcon A
Active Comparator group
Description:
Subjects wear 3 multifocal contact lenses: senofilcon A production worn first, senofilcon A test worn second, and balafilcon A worn third.
Treatment:
Device: balafilcon A
Device: senofilcon A production
Device: senofilcon A test
senofilcon A prod/ balifilcon A/ senofilcon A test
Active Comparator group
Description:
Subjects wear 3 multifocal contact lenses: senofilcon A production worn first, balafilcon A worn second, and senofilcon A test worn third.
Treatment:
Device: balafilcon A
Device: senofilcon A production
Device: senofilcon A test
balafilcon A/senofilcon A test/senofilcon A prod
Active Comparator group
Description:
Subjects wear 3 multifocal contact lenses: balafilcon A worn first, senofilcon A test worn second, and senofilcon A production worn third.
Treatment:
Device: balafilcon A
Device: senofilcon A production
Device: senofilcon A test
balafilcon A/senofilcon A prod/senofilcon A test
Active Comparator group
Description:
Subjects wear 3 multifocal contact lenses: balafilcon A worn first, senofilcon A production worn second, senofilcon A test worn third.
Treatment:
Device: balafilcon A
Device: senofilcon A production
Device: senofilcon A test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems